These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 6863937

  • 21. [Experimental analysis of cytotoxicity mediated by activated macrophages against glioma cells in mice].
    Ohyama K.
    Nihon Geka Hokan; 1993 Mar 01; 62(2):92-115. PubMed ID: 8239865
    [Abstract] [Full Text] [Related]

  • 22. Vaccination routes that fail to elicit protective immunity against Schistosoma mansoni induce the production of TGF-beta, which down-regulates macrophage antiparasitic activity.
    Williams ME, Caspar P, Oswald I, Sharma HK, Pankewycz O, Sher A, James SL.
    J Immunol; 1995 May 01; 154(9):4693-700. PubMed ID: 7722322
    [Abstract] [Full Text] [Related]

  • 23. Schistosoma mansoni and S. japonicum worm numbers in 129/J mice of two types and dominance of susceptibility in F1 hybrids.
    Wright MD, Tiu WU, Wood SM, Walker JC, Garcia EG, Mitchell GF.
    J Parasitol; 1988 Aug 01; 74(4):618-22. PubMed ID: 2969409
    [Abstract] [Full Text] [Related]

  • 24. Regulation of activated macrophage antimicrobial activities. Cooperation of lymphokines for induction of resistance to infection.
    Davis CE, Belosevic M, Meltzer MS, Nacy CA.
    J Immunol; 1988 Jul 15; 141(2):627-35. PubMed ID: 3133412
    [Abstract] [Full Text] [Related]

  • 25. Taxol provides a second signal for murine macrophage tumoricidal activity.
    Manthey CL, Perera PY, Salkowski CA, Vogel SN.
    J Immunol; 1994 Jan 15; 152(2):825-31. PubMed ID: 7506736
    [Abstract] [Full Text] [Related]

  • 26. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
    Fogler WE, Talmadge JE, Fidler IJ.
    J Reticuloendothel Soc; 1983 Mar 15; 33(3):165-74. PubMed ID: 6834360
    [Abstract] [Full Text] [Related]

  • 27. Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. IV. Analysis of the role of IgE antibodies and mast cells.
    Sher A, Correa-Oliveira R, Hieny S, Hussain R.
    J Immunol; 1983 Sep 15; 131(3):1460-5. PubMed ID: 6193190
    [Abstract] [Full Text] [Related]

  • 28. Dissociation between macrophage tumoricidal capacity and suppressive activity: analysis with macrophage-defective mouse strains.
    Boraschi D, Pasqualetto E, Ghezzi P, Salmona M, Bartalini M, Barbarulli G, Censini S, Soldateschi D, Tagliabue A.
    J Immunol; 1983 Oct 15; 131(4):1707-13. PubMed ID: 6311895
    [Abstract] [Full Text] [Related]

  • 29. Virus-induced immune complex disease: genetic control of C1q binding complexes in the circulation of mice persistently infected with lymphocytic choriomeningitis virus.
    Oldstone MB, Tishon A, Buchmeier MJ.
    J Immunol; 1983 Feb 15; 130(2):912-8. PubMed ID: 6217255
    [Abstract] [Full Text] [Related]

  • 30. Genetic differences in BCG-induced resistance to Schistosoma mansoni are not controlled by genes within the major histocompatibility complex of the mouse.
    Civil RH, Mahmoud AA.
    J Immunol; 1978 Mar 15; 120(3):1070-2. PubMed ID: 344795
    [Abstract] [Full Text] [Related]

  • 31. Lung-phase immunity to Schistosoma mansoni. Flow cytometric analysis of macrophage activation states in vaccinated mice.
    Menson EN, Wilson RA.
    J Immunol; 1989 Oct 01; 143(7):2342-8. PubMed ID: 2506284
    [Abstract] [Full Text] [Related]

  • 32. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.
    Gilbreath MJ, Nacy CA, Hoover DL, Alving CR, Swartz GM, Meltzer MS.
    J Immunol; 1985 May 01; 134(5):3420-5. PubMed ID: 3980997
    [Abstract] [Full Text] [Related]

  • 33. Defective vaccine-induced immunity to Schistosoma mansoni in P strain mice. I. Analysis of antibody responses.
    Correa-Oliveira R, Sher A, James SL.
    J Immunol; 1984 Sep 01; 133(3):1581-6. PubMed ID: 6747298
    [Abstract] [Full Text] [Related]

  • 34. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R, Tallima H.
    Vaccine; 2009 Jan 29; 27(5):666-73. PubMed ID: 19056448
    [Abstract] [Full Text] [Related]

  • 35. Natural resistance to listeriosis: role of host inflammatory responsiveness.
    Stevenson MM, Gervais F, Skamene E.
    Clin Invest Med; 1984 Jan 29; 7(4):297-301. PubMed ID: 6442652
    [Abstract] [Full Text] [Related]

  • 36. Hybrid resistance to BALB/c plasmacytomas: F1 hybrid anti-MPC-11 immunological responses correlated with resistance to tumor challenge.
    Marsili MA, Walker MC, Phillips-Quagliata JM.
    Cancer Res; 1986 Jan 29; 46(1):190-7. PubMed ID: 3484380
    [Abstract] [Full Text] [Related]

  • 37. Genetic linkage of resistance to Listeria monocytogenes with macrophage inflammatory responses.
    Stevenson MM, Kongshavn PA, Skamene E.
    J Immunol; 1981 Aug 29; 127(2):402-7. PubMed ID: 7252146
    [Abstract] [Full Text] [Related]

  • 38. [Effects of interferon-gamma on cytotoxicity of murine activated macrophages against murine glioma cells].
    Ohyama K, Kikuchi H, Oda Y, Moritake K, Yamasaki T.
    No To Shinkei; 1993 Jun 29; 45(6):525-30. PubMed ID: 8363848
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effector mechanism in concomitant immunity potentiated by intratumoral injection of Nocardia rubra cell wall skeleton.
    Ogura T, Hara H, Yokota S, Hosoe S, Kawase I, Kishimoto S, Yamamura Y.
    Cancer Res; 1985 Dec 29; 45(12 Pt 1):6371-5. PubMed ID: 4063987
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.